Why lipoprotein(a) matters for clinical decisions and patient risk? - report from ACC.25
Martha Gulati shares her insights on lipoprotein(a) and atherosclerotic cardiovascular disease at the American College of Cardiology’s Annual Scientific Session. She discussed studies such as HORIZON and the ALPACA trial.Video: https://medicaldigest.org/scientific-contents/interview:why-lipoprotein-matters-clinical-decisions-and-patient-risk